Identification of peptide sequences that target to the brain using in vivo phage display

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Amino Acids

• Publication date

  2011-07-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00726-011-0979-yPMID 21792566
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model.

  2011cited by this paper
• Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases.

  2010cited by this paper
• Structure and function of the blood-brain barrier.

  2010cited by this paper
• Identification of Peptide Ligands for Targeting to the Blood-Brain Barrier

  2010cited by this paper
• Phage display: concept, innovations, applications and future.

  2010cited by this paper
• Identification of nose-to-brain homing peptide through phage display.

  2009cited by this paper
• Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB).

  2009cited by this paper
• Chapter 3 - Colloidal systems for CNS drug delivery.

  2009cited by this paper
• Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations.

  2009cited by this paper
• Identification and Design of Peptides as a New Drug Delivery System for the Brain

  2008cited by this paper
• Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep‐2

  2008cited by this paper
• Active targeting of brain tumors using nanocarriers.

  2007cited by this paper
• Synchronous selection of homing peptides for multiple tissues by in vivo phage display

  2006cited by this paper
• Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease.

  2005cited by this paper
• Physiology of the blood–brain barrier and its consequences for drug transport to the brain

  2005cited by this paper
• Delivery of β-Galactosidase to Mouse Brain via the Blood-Brain Barrier Transferrin Receptor

  2005cited by this paper
• Strategies to optimize brain penetration in drug discovery.

  2005cited by this paper
• Molecular biology of the blood-brain barrier.

  2005cited by this paper
• Molecular biology of the blood-brain barrier

  2005cited by this paper
• Filamentous phage display in the new millennium.

  2005cited by this paper
• A Novel Peptide Specifically Binding to Nasopharyngeal Carcinoma For Targeted Drug Delivery

  2004cited by this paper
• Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

  2004cited by this paper
• The blood-brain barrier: an overview: structure, regulation, and clinical implications.

  2004cited by this paper
• Biodistribution of filamentous phage peptide libraries in mice

  2004cited by this paper
• Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis.

  2003cited by this paper
• Targeting the EphA4 receptor in the nervous system with biologically active peptides.

  2003cited by this paper
• Targeting the prostate for destruction through a vascular address

  2002cited by this paper
• Engineering M13 for phage display.

  2001cited by this paper
• Phage Display: A Laboratory Manual

  2001cited by this paper
• Receptor mediated uptake of peptides that bind the human transferrin receptor.

  2001cited by this paper
• Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.

  2000cited by this paper
• Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display.

  2000cited by this paper
• The basic structure of filamentous phage and its use in the display of combinatorial peptide libraries

  1999cited by this paper
• The basic structure of filamentous phage and its use in the display of combinatorial peptide libraries.

  1999cited by this paper
• Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display.

  1998cited by this paper
• Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model.

  1998cited by this paper
• Phage Display.

  1997cited by this paper
• αv Integrins as receptors for tumor targeting by circulating ligands

  1997cited by this paper
• Organ targeting In vivo using phage display peptide libraries

  1996cited by this paper
• Toward cell–targeting gene therapy vectors: Selection of cell–binding peptides from random peptide–presenting phage libraries

  1996cited by this paper
• Brain drug delivery of small molecules using immunoliposomes.

  1996cited by this paper
• Isolation of a highly specific ligand for the alpha 5 beta 1 integrin from a phage display library

  1994cited by this paper
• The collagen receptor alpha 2 beta 1, from MG-63 and HT1080 cells, interacts with a cyclic RGD peptide.

  1992cited by this paper
• New perspectives in cell adhesion: RGD and integrins.

  1987cited by this paper
• Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface.

  1985cited by this paper

• A Beautiful Bind: Phage Display and the Search for Cell-Selective Peptides

  2025cites this paper
• Simple molecules make difference: short peptides play a novel role in slowing senescence

  2025cites this paper
• On the origin of non-specific binders isolated in the selection of phage display peptide libraries

  2025cites this paper
• Advanced nanoparticle engineering for precision therapeutics of brain diseases.

  2025cites this paper
• Precision drug delivery to the central nervous system using engineered nanoparticles

  2024cites this paper
• Peptide-based non-viral gene delivery: A comprehensive review of the advances and challenges.

  2024cites this paper
• Identifying molecular tags selectively retained on the surface of brain endothelial cells to generate artificial targets for therapy delivery

  2023cites this paper
• Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges

  2022cites this paper
• Phage Particles of Controlled Length and Genome for In Vivo Targeted Glioblastoma Imaging and Therapeutic Delivery.

  2022cites this paper
• Forging the Frontiers of Image-Guided Neurosurgery—The Emerging Uses of Theranostics in Neurosurgical Oncology

  2022cites this paper
• Current Update on Transcellular Brain Drug Delivery

  2022cites this paper
• Transmorphic phage‐guided systemic delivery of TNFα gene for the treatment of human pediatric medulloblastoma

  2022cites this paper
• Peptide Shuttles for Blood–Brain Barrier Drug Delivery

  2022cites this paper
• Brain Targeting and Aβ Binding Bifunctional Nanoparticles Inhibit Amyloid Protein Aggregation in APP/PS1 Transgenic Mice.

  2021cites this paper
• Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases.

  2021cites this paper
• DNA-Encoded Multivalent Display of Protein Tetramers on Phage: Synthesis and In Vivo Aplications

  2021cites this paper
• DNA-Encoded Multivalent Display of Chemically Modified Protein Tetramers on Phage: Synthesis and in Vivo Applications.

  2021cites this paper
• Drug delivery to the central nervous system

  2021cites this paper
• Development of Novel Therapeutics Targeting the Blood–Brain Barrier: From Barrier to Carrier

  2021cites this paper
• Introduction of Surface Loops as a Tool for Encapsulin Functionalization

  2021cites this paper
• A novel CNS-homing peptide for targeting neuroinflammatory lesions in experimental autoimmune encephalomyelitis.

  2020cites this paper
• Phage nanofibers in nanomedicine: Biopanning for early diagnosis, targeted therapy, and proteomics analysis.

  2020cites this paper
• Targeting Ligands Deliver Model Drug Cargo into the Central Nervous System along Autonomic Neurons.

  2019cites this paper
• Production and Bioengineering of Recombinant Pharmaceuticals

  2019cites this paper
• Optical Imaging of Triple-Negative Breast Cancer Cells in Xenograft Athymic Mice Using an ICAM-1-Targeting Small-Molecule Probe

  2019cites this paper
• Bacteriophages engineered to display foreign peptides may become short‐circulating phages

  2019cites this paper
• Peptide Phage Display: Molecular Principles and Biomedical Applications

  2019cites this paper
• Peptide Phage Display: Molecular Principles and Biomedical Applications

  2019cites this paper
• Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies

  2019cites this paper
• The Development of a Drug Delivery System Using Brain Endothelial Non-Antibody Binding Domains as Transport Carriers

  2018cites this paper
• A Peptide Targeting Inflammatory CNS Lesions in the EAE Rat Model of Multiple Sclerosis

  2018cites this paper
• Selection and identification of novel peptides specifically targeting human cervical cancer

  2018cites this paper
• Targeting extracellular vesicles to injured tissue using membrane cloaking and surface display

  2018cites this paper
• Phage-displayed peptides targeting specific tissues and organs

  2018cites this paper
• Identification of a Peptide for Systemic Brain Delivery of a Morpholino Oligonucleotide in Mouse Models of Spinal Muscular Atrophy

  2017cites this paper
• Peptides as drug delivery vehicles across biological barriers

  2017cites this paper
• Phage display as a tool to discover blood–brain barrier (BBB)‐shuttle peptides: panning against a human BBB cellular model

  2017cites this paper
• Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.

  2016cites this paper
• The further characterization of the peptide specifically binding to gastric cancer.

  2016cites this paper
• Discovery of novel peptides targeting pro-atherogenic endothelium in disturbed flow regions -Targeted siRNA delivery to pro-atherogenic endothelium in vivo

  2016cites this paper
• The HGF inhibitory peptide HGP-1 displays promising in vitro and in vivo efficacy for targeted cancer therapy

  2015cites this paper
• M13 phage peptide ZL4 exerts its targeted binding effect on schistosoma japonicum via alkaline phosphatase.

  2015cites this paper
• Phage display: development of nanocarriers for targeted drug delivery to the brain

  2015cites this paper
• A synthetic peptide inhibits human ovarian cancer cell motility

  2015cites this paper
• FUNCTION OF DISINTEGRIN-LIKE DOMAIN OF KSHV gB IN REGULATING VIRUS INFECTION

  2015cites this paper
• Novel Approaches for the Delivery of Biologics to the Central Nervous System

  2015cites this paper
• Cancer Cell-Specific Oligopeptides Selected by an Integrated Microfluidic System from a Phage Display Library for Ovarian Cancer Diagnosis

  2015cites this paper
• Combinatorial approaches for the identification of brain drug delivery targets.

  2014cites this paper
• Identification and characterization of a novel phage display-derived peptide with affinity for human brain metastatic breast cancer

  2014cites this paper
• Vascular-homing peptides for targeted drug delivery and molecular imaging: meeting the clinical challenges.

  2014cites this paper
• Bacteriophages and medical oncology: targeted gene therapy of cancer

  2014cites this paper
• A novel peptide specifically targeting ovarian cancer identified by in vivo phage display

  2013cites this paper
• Design of brain imaging agents for positron emission tomography: do large bioconjugates provide an opportunity for in vivo brain imaging?

  2013cites this paper
• In vivo phage display--a discovery tool in molecular biomedicine.

  2013cites this paper
• [Research advances in brain-targeted nanoscale drug delivery system].

  2013cites this paper
• A novel in vivo method for isolating antibodies from a phage display library by neuronal retrograde transport selectively yields antibodies against p75NTR

  2013cites this paper
• Chemical synthesis and orexigenic activity of rat/mouse relaxin-3

  2013cites this paper
• A novel peptide ligand directed targeted drug delivery to Myeloid-derived suppressor cells ( MDSCs ) in tumor bearing mouse

  2013cites this paper